ChemoCentryx, Inc.
850 Maude Avenue
Mountain View, CA 94043
May 15, 2019
VIA EDGAR
Mr. Jeffrey Gabor
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E., Mail Stop 4546
Washington, D.C. 20549
Re: | ChemoCentryx, Inc. |
Registration Statement on FormS-3 |
Filed May 7, 2019 |
FileNo. 333-231257 |
Dear Mr. Gabor:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of ChemoCentryx, Inc., respectfully requests that the effective date of the Registration Statement on FormS-3 referred to above be accelerated so that it will become effective at 5:00 P.M. Eastern Time on Friday, May 17, 2019, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Michael E. Sullivan, Esq. of Latham & Watkins LLP at (858)523-3959. Thank you for your assistance and cooperation in this matter.
Very truly yours,
CHEMOCENTRYX, INC. | ||
By: | /s/ Thomas J. Schall, Ph.D. | |
Thomas J. Schall, Ph.D. President and Chief Executive Officer |
cc: | Michael E. Sullivan, Esq.,Latham & Watkins LLP |
Denis J. Griffin, Esq., Latham & Watkins LLP